Ramanan Laxminarayan: The coming crisis in antibiotics
Ramanan Laxminarayan: Nadchodzący kryzys antybiotykowy
At the Center for Disease Dynamics, Economics & Policy, economist Ramanan Laxminarayan looks at big-picture issues of global health. Full bio
Double-click the English transcript below to play the video.
treated with an antibiotic
while working in the garden.
podczas pracy w ogródku.
his head was swollen
głowa mu spuchła,
used to treat a human,
knew if the drug would work,
that would kill the patient,
they might as well use it
his appetite came back.
run out of penicillin,
was run with his urine
the penicillin from his urine
na dobrej drodze do wyzdrowienia.
millions of other people,
again in the early 1940s,
leczone na początku lat 40.,
wonder drug, penicillin.
used rather frivolously
with just a cold or the flu,
responded to an antibiotic,
used in large quantities
means in small concentrations,
on the price of meat,
na cenie mięsa,
antibiotics on animals,
selection pressure on bacteria
about this in the newspapers,
of carbapenem resistance in acinetobacter.
bakterii Acinetobacter na karbapenemy.
paskudny szpitalny patogen,
across the United States.
when we play the video.
you might say, well,
to use antibiotics as much,
jak nie nadużywać antybiotyków,
not to demand antibiotics,
nie domagać się antybiotyków,
fundamental about antibiotics
others are affected as well,
ale i na innych,
choose to drive to work
czy jadę do pracy samochodem,
są ponoszone wszędzie,
these costs into consideration.
biorę te koszty pod uwagę.
call a problem of the commons,
"problemem wspólnego pastwiska"
of antibiotics as well:
kosztów nakładanych na innych
that they impose on others
and climate change.
zanieczyszczenia i zmian klimatu.
you can deal with the problem.
use of the oil that we have,
korzystać z posiadanej ropy,
"drill, baby, drill" option,
"Drąż, skarbie, drąż".
is to go find new antibiotics.
to poszukiwanie nowych leków.
bo jeśli sporo zainwestujemy
for conservation of oil
do oszczędzania ropy,
to happen for antibiotics.
to happen, which is that
antybiotyki prawidłowo,
to make the investments
this particular picture,
potrafią szybciej biegać,
playing against the bacteria,
ahead of the bacteria?
game that can be sustained,
ciągłymi innowacjami.
can borrow from energy
zaczerpnąć z energii,
the costs of pollution
w przypadku antybiotyków
which don't pollute as much
które mniej zanieczyszczają
good substitutes for antibiotics?
hospital infection control
nad zakażeniami szpitalnymi
the seasonal influenza.
większego użycia antybiotyków
as in many other countries,
something like tradeable permits.
zbywalne pozwolenia.
fact that we might not
people who have infections,
be on the basis of clinical need,
potrzeby kliniczne,
informational feedback,
some information back
been introduced since then —
paying 10 cents a day for antibiotics,
10 centów dziennie za antybiotyki,
antibiotics as a given
skutecznych antybiotyków za pewnik
looking at other technologies,
przyjrzeć się innym technologiom,
gasoline prices are a signal
seem unusual for antibiotics,
niespotykane w przypadku antybiotyków,
for a few months or perhaps a year,
na kilka miesięcy lub rok,
antibiotics starts going higher,
nowych antybiotyków.
market does actually respond,
antibiotics and development.
nowych antybiotyków i ich rozwoju.
i sprzedaży antybiotyków.
permanent solutions.
whatever the technology might be,
że niezależnie od technologii,
way to work around it.
this is just a problem
have the exact same
many other fields as well,
in India and South Africa.
w Indiach i Południowej Afryce.
nawet one nie działają.
Pierwotniaki wywołujące malarię.
treat malaria around the world
safe and efficacious.
pewnie słyszeliście o wszach głowowych.
know about head lice,
specialty there is bedbugs.
example from across the pond.
z drugiej strony Atlantyku.
also resistant to poisons.
że szczury są odporne na trucizny.
to all of these things is
the last 70, 80 or 100 years
przez ostatnie 70, 80, czy 100 lat
evolution was going to find
znajdą sposób,
start thinking about them
ABOUT THE SPEAKER
Ramanan Laxminarayan - Drug-resistance economistAt the Center for Disease Dynamics, Economics & Policy, economist Ramanan Laxminarayan looks at big-picture issues of global health.
Why you should listen
Economist Ramanan Laxminarayan works to improve understanding of drug resistance as a problem of managing a shared global resource. As Director and Senior Fellow at the Center for Disease Dynamics, Economics & Policy (CDDEP), he is interested in cross-disciplinary, pragmatic solutions to reduce drug resistance. He has advised the World Health Organization and World Bank on evaluating malaria treatment policy, vaccination strategies, the economic burden of tuberculosis, and control of non-communicable diseases. He was a key architect of the Affordable Medicines Facility for malaria, a novel financing mechanism to improve access and delay resistance to antimalarial drugs. In 2012, he created the Immunization Technical Support Unit in India, which has been credited with improving the immunization program in the country. He teaches at Princeton.
As he says: "It has been a long time since people died of untreatable bacterial infections, and the prospect of returning to that world is worrying."Ramanan Laxminarayan | Speaker | TED.com